InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-01-13 | April McClain Delaney(D-MD06) | house | Sale | $1,001 - $15,000 |
| 2025-12-02 | April McClain Delaney(D-MD06) | house | Purchase | $1,001 - $15,000 |
| 2025-10-16 | April McClain Delaney(D-MD06) | house | Sale | $1,001 - $15,000 |
| 2025-09-04 | Byron Donalds(R-FL19) | house | Purchase | $1,001 - $15,000 |
| 2025-08-07 | April McClain Delaney(D-MD06) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenue | $1.76B+7.0% | $1.65B+5.0% | $1.57B+9.2% | $1.44B+7.4% | $1.34B |
| Total cost of revenue | $839.5M+4.6% | $802.5M+6.6% | $753.0M+6.6% | $706.5M+5.6% | $669.1M |
| Gross profit | $2.66B+11.8% | $2.38B+8.6% | $2.19B+9.3% | $2.00B+6.1% | $1.89B |
| Sales and marketing | $643.5M+9.4% | $588.5M+4.0% | $566.1M+7.9% | $524.5M+7.8% | $486.7M |
| General and administrative | $404.8M-8.5% | $442.3M+31.7% | $335.8M+2.9% | $326.2M+5.4% | $309.7M |
| Research and development | $251.2M+14.3% | $219.8M+15.1% | $191.0M-25.1% | $254.8M+58.3% | $161.0M |
| Total operating expenses | $1.30B+3.9% | $1.25B+14.4% | $1.09B-1.2% | $1.11B | — |
| Income from operations | $1.36B+20.5% | $1.13B+2.8% | $1.10B+22.1% | $898.8M-3.6% | $932.0M |
| Interest expense | -$38.9M-24.5% | -$31.2M+25.0% | -$41.6M-4.3% | -$39.9M-33.7% | -$29.8M |
| Interest income | $3.0M-76.3% | $12.7M+125.6% | $5.6M+428.5% | $1.1M+145.4% | $434K |
| Income before provision for income taxes | $1.32B+19.3% | $1.11B+4.6% | $1.06B+23.4% | $860.0M-4.7% | $902.7M |
| Provision for income taxes | $264.7M+19.3% | $222.0M+2.7% | $216.1M+19.5% | $180.9M+14.6% | $157.8M |
| Net income | $1.06B+19.3% | $887.9M+5.1% | $845.0M+24.4% | $679.1M-8.8% | $744.8M |
| Basic (in USD per share) | $13K+22.3% | $11K+5.9% | $10K+25.2% | $8K-7.1% | $9K |
| Diluted (in USD per share) | $13K+22.6% | $11K+6.1% | $10K+25.3% | $8K-6.6% | $9K |
| Basic (in shares) | $80.4M-2.5% | $82.5M-0.7% | $83.1M-0.7% | $83.6M-1.9% | $85.2M |
| Diluted (in shares) | $81.0M-2.7% | $83.2M-0.9% | $84.0M-0.7% | $84.6M-2.3% | $86.6M |
| Product revenue | |||||
| Total revenue | $1.76B+7.0% | $1.65B+5.0% | $1.57B+9.2% | $1.44B+7.4% | $1.34B |
| Total cost of revenue | $839.5M+4.6% | $802.5M+6.6% | $753.0M+6.6% | $706.5M+5.6% | $669.1M |
| Service revenue | |||||
| Total revenue | $1.76B+7.0% | $1.65B+5.0% | $1.57B+9.2% | $1.44B+7.4% | $1.34B |
| Total cost of revenue | $839.5M+4.6% | $802.5M+6.6% | $753.0M+6.6% | $706.5M+5.6% | $669.1M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
What Analyst Projections for Key Metrics Reveal About Idexx (IDXX) Q1 Earnings
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1?
IDEXX Laboratories Vs. Zoetis: A Pre-Earnings Comparison